Overview

SMi is proud to present the 17th instalment in the established sell-out conference series; Superbugs and Superdrugs, taking place on 25th and 26th March 2015 in Central London.

Antibiotics have been one of the most transformational discoveries in medicine saving millions of lives around the world. The rise of resistance poses an unprecedented threat to public health rekindling a drive for new, effective and safe drugs to beat the superbugs, combined with efforts to raise awareness around the use of antimicrobials.

Superbugs and Superdrugs 2015 takes a holistic look at the issues and aims to equip delegates to take on the challenges of conserving the effectiveness of existing antibacterial drugs, developing new ones and tackling biosecuiry and Ebola threats. Bringing in voices from pharma, academia, government, regulatory perspectives, consultants and funding bodies this conference is the ideal meeting place to share the latest updates, case studies and strategies to seize the opportunities ahead and usher in the next generation of superdrugs.

KEY SPEAKERS INCLUDE:

• Richard Bax, Senior Partner, TranScrip Partners - CHAIR FOR 2015
• Jorge Mestre-Ferrandiz, Director of Consulting, Office of Health Economics (OHE)
• Shiva Dustdar, Head of Research, Development and Innovation Advisory, European Investment Bank (EIB)
• Domingo Gargallo-Viola, CSO, ABAC Therapeutics
• Fiona Marston, Chief Executive, Absynth Biologics
• Colin J Suckling, Research Professor of Chemistry, University of Strathclyde
• David Findlay, Commercial Director of II-ID Global Franchise, GSK
• William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center

REASONS TO ATTEND:

• Receive the latest updates and case studies on preclinical and clinical developments
• Scan horizons on anti-microbial resistance and understand initiatives to control antimicrobial use
• Look at alternative approaches including phage and minor groove binders
• Explore the latest updates in funding and reimbursement
• Review the current status of antimicrobial resistance and the threats and targets landscape
• Discuss the potential of rapid point of care diagnostics

Previous instalments in the series have received positive feedback from the industry including "Very well organised conference" – GSK, "Good level of quality" – Janssen, "Very good and engaging speakers" – Merck and "Good topics, mix of basic research and clinical development and perspectives" - J&J

This really is a unique event not be missed. Download the brochure today and secure your place at www.superbugssuperdrugs.com

Alternatively contact Fateja Begum on +44 (0)20 7827 6184 or email fbegum@smi-online.co.uk



Venue: Holiday Inn Regents Park Hotel
Location: Carburton Street, London
Country: United Kingdom

Organiser Contact Details:
SMi Group Ltd
T: +44 (0)20 7827 6000
tarri@smi-online.co.uk